Piper Sandler

Moxe Health streamlines the bi-directional exchange of clinical data between health plans and provider systems. The company provide solutions for risk adjustment, HEDIS and Star ratings, claims denial management, HCC reconciliation, patient summary, ADT notifications, and care gap management. Plans seamlessly send back data and insights while never straying from clinicians’ EHR workflows. Moxe’s clinical data clearinghouse allows health plans to easily receive information from health systems. Health plans can then seamlessly send back data and insights. With automated solutions for risk adjustment, quality, and care management programs, Moxe facilitates access to the information essential to your success in the market shift to value-based care. Moxe’s neutrality in providing data connectivity lets you realize the full potential of your existing investments in population health, quality, and analytics solutions.

Paragon 28, Inc. provides forefoot, midfoot, and hindfoot plates; and screws, allograft bone systems, and interference screws and staples for use in foot and ankle surgery. The company’s products also serve arthrodesis needs.

Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.

Clinicient, Inc. is a technology company specializing in software solutions for outpatient rehabilitation clinics, primarily focusing on physical therapy. Founded in 1998 and based in Portland, Oregon, Clinicient offers a range of products including TotalInsight, which integrates cloud-based electronic medical records (EMR) with billing services and revenue cycle management. Additionally, PracticeInsight provides a unified system for EMR and billing, while InsightEMR is a customizable EMR tailored for therapy providers. The company also addresses Medicare requirements with services such as functional limitation reporting and claims management. Clinicient’s platform streamlines patient registration, scheduling, clinical documentation, and billing processes, enabling clinics to enhance revenue management and improve payment outcomes.

Sandler O’Neill + Partners is a full-service investment banking firm and broker-dealer focused on the financial services sector. Its clients include a wide variety of financial firms nationwide, and increasingly, around the globe. The firm provides the full suite of investment banking services, including merger and acquisition advisory, capital markets, fixed income and equity trading and sales, equity research, balance sheet management, mortgage finance and consulting services to financial institutions and their investors. Sandler O’Neill is a partnership, and different by design. Since the firm’s founding in 1988, its partners have sought to provide banks, thrifts and other financial services companies with an alternative to large Wall Street banking firms. The firm's focus has always been to enhance franchise value for clients within known, managed risk parameters. We provide clients a wealth of experience and knowledge more critical to them today than ever.

Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.

Weeden & Co. is an employee-owned limited partnership. This structure allows all employees to participate in the success of the firm. Their success is wholly dependent upon listening to our clients, and upon delivering superior execution solutions. Their partnership fosters teamwork, loyalty, and a deep appreciation for each other and for our clients.

Foodsby LLC operates a Website that enables restaurants to deliver food or lunch to offices. The company was incorporated in 2012 and is based in Minneapolis, Minnesota.

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections. The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load often associated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S. Xenex was founded in 2009 and headquartered in San Antonio, Texas.

OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.

Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota.

From earth to sky. Our scientists discovered and industrialized a game-changing additive manufacturing technology for the production of aerospace-grade titanium structures. From refining raw ore found in nature into the pure wire we use to make safety-critical aircraft parts, we have never wavered in our quest to achieve more while consuming less. The new industrial revolution is here. Our proprietary plasma arc Rapid Plasma Deposition™ (RPD™) technology is the ultimate in additive manufacturing. Titanium wire is melted in a cloud of argon gas and precisely and rapidly built up in layers to a near-net-shape (up to 80% complete) that requires very little finish machining. Production cost is 50% to 75% less than legacy forging and billet manufacturing techniques due to significantly less waste and machining energy.

OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.

Simmons & Company International is one of the largest and most experienced independent investment banks specializing in the energy industry, offering unparalleled M&A advisory, capital markets execution and investment research. By leveraging the collective knowledge of their growing team of approximately 150 professionals, they stay on the forefront of the industry's trends, drivers and developments and are also positioned to access the most strategic opportunities for their clients. Over the last four decades they have established theirselves as a premier partner in virtually every energy sector, serving a worldwide client base ranging from institutional investors, public and private companies and private equity firms. Their extensive market coverage and industry knowledge has not only profoundly shaped their unique perspective, but empowers clients to understand the energy sector in a new light.

GutCheck specializes in online agile market research that equips and empowers the world’s most innovative brands to unlock bold new possibilities by harnessing the power of agile technology and human empathy. We empower brands with the insights to make decisions throughout the innovation cycle and meet you where you are in the process.

PerfectServe, Inc. provides physician contact and patient care communication services to hospitals, physician practices and other healthcare clients in more than 130 markets across the U.S. Since 2000, the company has experienced compound annual growth in excess of 50 percent, demonstrating the market demand for our innovative physician contact offerings, PerfectServe One-2-Oneâ„¢ and PerfectServe OnCall.â„¢ Independent research has found that the PerfectServe platform is able to provide medical professionals with unprecedented accuracy, reliability and personal control over physician contact processes. At present, PerfectServe facilitates tens of thousands of interactions per day between our hospital and physician clients and their approximately 12 million patients.

River Branch Holdings LLC, an international merchant bank, was founded to provide differentiated solutions in Investment Banking and Investment Management. Our business revolves around partnerships — partnering with our clients, our investors and our stakeholders. With well over 100 years of combined expertise, River Branch offers its partners insightful knowledge, hands-on experience and long-term relationships.

Lattice Engines is a computer software company that specializes in the fields of marketing, sales, data-driven business applications, and trigger events. Its applications combine buying signals and apply advanced machine learning to help drive predictable marketing and sales performance. The company was founded in 2006 and is headquartered in San Mateo, California.

SportsEngine is the leading provider of web software and mobile applications for youth, amateur and professional sports. Powering more than 500,000 sports teams, leagues, clubs, and associations, SportsEngine features a complete suite of easy-to-use tools that help sports organizations manage, connect, and communicate with a diverse range of stakeholders including athletes, parents, administrators, coaches, referees, scouts, volunteers, fans, journalists, and sponsors.

Edgeview Partners is a specialized investment bank serving the unique merger and acquisition (M&A) advisory needs of middle-market clients. Founded in 2001, our firm advises clients across the United States and Canada in virtually all industries, typically working with companies ranging in enterprise value from $25 million to $500 million. Our main focus is on the sale of privately held companies backed by entrepreneurs, families or private equity groups, as well as divisions of larger corporations. We also have extensive experience advising on growth capital raises, recapitalization transactions and buy-side acquisitions. Our qualified team of professionals has diverse expertise advising on middle-market mergers and acquisitions, having completed over 350 successful transactions throughout their careers. We combine senior-level commitment and significant resources to deliver unmatched client service. Our creativity and superior results for a broad spectrum of clients have been recognized with numerous industry awards, including recognition by The M&A Advisor as Boutique Investment Bank of the Year and multiple Deal of the Year awards.

Vitals Consumer Services, LLC specializes in healthcare transparency and engagement solutions for consumers, employers, and health plans. Established in 2006 and headquartered in Lyndhurst, New Jersey, the company offers various tools to assist individuals in navigating their healthcare options. Among its key offerings are an online search tool for finding doctors, a healthcare transparency platform that clarifies health benefits and care choices, and an incentive program that rewards patients for selecting cost-effective care. Vitals serves over 280 million people annually, helping them make informed decisions about their healthcare. As of August 2018, Vitals operates as a subsidiary of WebMD Health Corp, with additional locations in New York, Tulsa, Westborough, and Bedford.

Oncolytics Biotech focuses the research and development efforts on the development of REOLYSIN, the cancer therapeutic. The product for human use, REOLYSIN is developed from the reovirus. The virus has been demonstrated to replicate in the tumour cells bearing an activated Ras pathway. The Ras protein is a regulator of cell growth and differentiation. It transmits signals from the cell's surface, through growth factor receptors, to downstream elements, which are in turn relayed to the nucleus. The transmission of signals from the cell surface to the cell's nucleus is referred to as the signal transduction. The wholly owned subsidiaries of the company include Oncolytics Biotech (Barbados) Inc. and Oncoltics Biotech (US) Inc. In April 2009, the Company completed the acquisition of an inactive private company. Oncolytics Biotech was founded on 1988 and is based in Calgary, Alberta, Canada.

Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota.

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications. The company's product development portfolio includes MultiStem, a stem cell product, that is being developed as a treatment for multiple disease indications, is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, Athersys develops pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy, or other forms of excessive daytime sleepiness.

PerfectServe, Inc. provides physician contact and patient care communication services to hospitals, physician practices and other healthcare clients in more than 130 markets across the U.S. Since 2000, the company has experienced compound annual growth in excess of 50 percent, demonstrating the market demand for our innovative physician contact offerings, PerfectServe One-2-Oneâ„¢ and PerfectServe OnCall.â„¢ Independent research has found that the PerfectServe platform is able to provide medical professionals with unprecedented accuracy, reliability and personal control over physician contact processes. At present, PerfectServe facilitates tens of thousands of interactions per day between our hospital and physician clients and their approximately 12 million patients.

BioHorizons is committed to developing evidence-based and scientifically-proven products. This commitment started with the launch of the Maestro implant system in 1997 and remains in full force today with our most recent launches, the Tapered Plus and Tapered 3.0 implant systems. The focus of BioHorizons on science, innovation and service enables our customers to confidently use our comprehensive portfolio of dental implants and biologics products making BioHorizons one of the fastest growing companies in the dental industry.

Living Proof was created for the purpose of applying advanced technology to solve the toughest beauty challenges from a completely fresh perspective. They are a team of scientists from outside beauty, led by MIT Institute Professor Dr. Bob Langer, and beauty authorities with a shared vision: to invent efficient formulas based on entirely new molecules and breakthrough technologies for results you can see from across the room.

IDEV Technologies is an emerging growth medical device company focused on the development of products for endovascular and interventional applications. Currently, IDEV markets SUPERA, a novel self-expanding nitinol stent. Using a patented interwoven design, SUPERA offers improved flexibility, radial strength, and kink and crush resistance compared to other marketed stents. SUPERA is currently approved for use in the treatment of biliary strictures in the US. IDEV is currently enrolling patients in the SUPERB IDE trial to study SUPERA's safety and efficacy when used in the superficial femoral artery (SFA).

Advisory Research delivers actively managed investment strategies, competitive risk-adjusted returns, and personalized, high-touch client service. They are specialized investment experts who maintain a collaborative culture based on idea sharing and entrepreneurial thinking to better serve clients with the expertise of the entire team. They offer separate account management as well as private funds to institutional and intermediary investors.

Pandora is the world’s most powerful music discovery platform, offering a personalized experience for each of our listeners wherever and whenever they want to listen to music—whether through mobile devices, car speakers or connected devices in the home. Unlike traditional radio that broadcasts the same content at the same time to all of its listeners, we enable our listeners to create personalized stations and playlists, as well as search and play songs and albums on-demand. The Music Genome Project, our content programming algorithms and data collected from our listeners power our ability to predict listener music preferences, play music content suited to the tastes of each individual listener and introduce listeners to the music we think they will love. Founded by musicians, Pandora also empowers artists with valuable data and tools to help grow their audience and connect with their fans. Pandora is available as an ad-supported radio service, a radio subscription service called Pandora Plus and an on-demand subscription service called Pandora Premium. The majority of our listener hours occur on mobile devices, with the majority of our revenue generated from advertising on our ad-supported radio service on these devices. With billions of data points that help us understand our users' preferences, we offer both local and national advertisers the opportunity to deliver targeted messages to our listeners using a combination of audio, display and video advertisements. We also generate increasing revenue from our subscription offerings.

Vidacare Corporation, a medical device company, engages in the development, manufacture, and marketing of intraosseous access devices for diagnostic, monitoring, and therapeutic applications. The company provides EZ-IO Product System, which is designed to provide controlled vascular access through the intraosseous route to patients in emergent situations when vascular access is challenging and impossible. It also offers EZ-IO power driver, which is designed to penetrate the intraosseous space by drilling through the bone with a hollow needle and integrated stylet that doubles as the forward cutting bit to secure its correct placement; and EZ-IO Vascular Access Pack, a kit developed for emergency medical specialists to provide access to IV and IO devices to gain vascular access. In addition, the company provides a suite of hematology/oncology products, including a power driver and needle sets for bone marrow aspiration and biopsy; and OnControl, a bone marrow system for clinicians to perform bone marrow aspiration and biopsy procedures. Its products are used in pre-hospital, emergency, crash cart, and rapid response applications, as well as in military and homeland security industries. Vidacare Corporation was founded in 2001 and is headquartered in San Antonio, Texas.

Pandora is the world’s most powerful music discovery platform, offering a personalized experience for each of our listeners wherever and whenever they want to listen to music—whether through mobile devices, car speakers or connected devices in the home. Unlike traditional radio that broadcasts the same content at the same time to all of its listeners, we enable our listeners to create personalized stations and playlists, as well as search and play songs and albums on-demand. The Music Genome Project, our content programming algorithms and data collected from our listeners power our ability to predict listener music preferences, play music content suited to the tastes of each individual listener and introduce listeners to the music we think they will love. Founded by musicians, Pandora also empowers artists with valuable data and tools to help grow their audience and connect with their fans. Pandora is available as an ad-supported radio service, a radio subscription service called Pandora Plus and an on-demand subscription service called Pandora Premium. The majority of our listener hours occur on mobile devices, with the majority of our revenue generated from advertising on our ad-supported radio service on these devices. With billions of data points that help us understand our users' preferences, we offer both local and national advertisers the opportunity to deliver targeted messages to our listeners using a combination of audio, display and video advertisements. We also generate increasing revenue from our subscription offerings.

eFashionSolutions is the leading provider of online flagship stores to the branded fashion apparel/accessories, entertainment, and specialty retail industries. The eFashionSolutions e-commerce services are supported by a comprehensive technology platform. Services include buying and merchandising, design, photography, e-marketing, business intelligence, customer service, order management, and fulfillment functions. The Company is led by apparel and retail executives with extensive experience in merchandising, branding, customer service, and the technology solutions required to effectively manage and grow an online retail business. In 2006, eFashionSolutions was named to the Inc. 500 and NJ Finest 50. In 2007, the company received the USPS Strategic Business Development Award for their global shipping program, was named a finalist by the Extended Retail Institute in the Multi-Channel category, and received a Webby Award Nomination for DKNY.com. eFashionSolutions ships to over 120 countries internationally.

Pandora is the world’s most powerful music discovery platform, offering a personalized experience for each of our listeners wherever and whenever they want to listen to music—whether through mobile devices, car speakers or connected devices in the home. Unlike traditional radio that broadcasts the same content at the same time to all of its listeners, we enable our listeners to create personalized stations and playlists, as well as search and play songs and albums on-demand. The Music Genome Project, our content programming algorithms and data collected from our listeners power our ability to predict listener music preferences, play music content suited to the tastes of each individual listener and introduce listeners to the music we think they will love. Founded by musicians, Pandora also empowers artists with valuable data and tools to help grow their audience and connect with their fans. Pandora is available as an ad-supported radio service, a radio subscription service called Pandora Plus and an on-demand subscription service called Pandora Premium. The majority of our listener hours occur on mobile devices, with the majority of our revenue generated from advertising on our ad-supported radio service on these devices. With billions of data points that help us understand our users' preferences, we offer both local and national advertisers the opportunity to deliver targeted messages to our listeners using a combination of audio, display and video advertisements. We also generate increasing revenue from our subscription offerings.

RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

Suros Surgical Systems, Inc. is an award winning Indiana-based medical device manufacturer setting new industry standards for minimally invasive methods of tissue excision and biopsy within multiple surgical specialties. Their patented surgical platform technology allows us to remove tissue or biopsy samples in the most compassionate, effective and efficient manner possible. Their initial product launch – the patented ATEC™ (Automated Tissue Excision and Collection) breast biopsy and excision system – has made exciting new clinical advancements in the areas of vacuum assisted diagnostic breast biopsy. Suros is proud to be the only company in the world with a commercially available MRI-guided vacuum assisted breast biopsy system that allows women in a high-risk population the opportunity for early diagnosis without going to surgery. For the more than 1.2 million women who undergo breast biopsy every year, this is good news. Suros also offers the first and only 9 gauge petite needle for women with small breasts and a true 12 gauge needle – giving physicians the world’s smallest needle to perform the world’s fastest breast biopsy. At Suros, they believe patients are better served with a minimally invasive approach to biopsy or surgery. The ATEC™ system offers measurable improvements in speed, reliability, clinical capabilities, safety, economic return, and ease of use. Simply stated, the ATEC™ is the choice both physicians and women have been waiting for – a breast biopsy system compatible under any imaging modality and first-ever technology that allows women a chance at outpatient breast biopsy methods with reduced pain and trauma, and with no scarring or post-op recovery time. Suros never stops improving its technology and is always looking for new, innovative ways of providing the most compassionate patient care on many clinical levels. Stay tuned as Suros grows and continues to take the lead in developing new capabilities for minimally invasive tissue excision in even the most delicate surgical applications.

Axya Medical is a U.S.-based company that offers knotless fixation systems for shoulder repair. The company provides knotless fixation systems, including control unit, handpiece, wielding sleeve, and sutures; and implants, including titanium implants, bioabsorbable implants, and super implants. Axya Medical also provides shoulder accessories such as removal tool, bone punch, bioabsorbable anchor tap, and drill guide with obturator; and general accessories, such as electrical cord, handpiece sterilization tray, protective horn sheath, suture separator, suture grasper, and arthroscopic suture cutter. It was founded in 1996 and is headquartered in Beverly, Massachusetts.

FieldCentrix provides mobile field service automation solutions for service lifecycle management. Its management solution, FieldCentrix Enterprise, automates and streamlines manual processes and centralizes disparate applications associated with field service. FieldCentrix delivers solutions for market sectors, including manufacturing, industrial equipment, automation controls, medical devices, high technology, communications, real estate services, and building trade services. The company was founded in 1994 and is headquartered in Irvine, California with offices in North America and Europe. As of September 21, 2005, FieldCentrix Inc. operates as a subsidiary of Astea International Inc.

InSound Medical, Inc., a privately held, venture-backed company based in Newark, California, develops and manufactures next-generation hearing solutions. Major investors include Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC.

Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for individuals with insulin-dependent diabetes. The company's primary product, the Omnipod System, consists of a disposable, tubeless insulin infusion device that adheres to the body for up to three days, along with a wireless personal diabetes manager for monitoring and control. Insulet markets its products through independent distributors and pharmacy channels, as well as directly to patients in the United States, Canada, Europe, and the Middle East. Founded in 2000, Insulet is headquartered in Acton, Massachusetts, and aims to enhance the quality of life for people managing diabetes through innovative technology.

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. Their proven LogPad and StudyPad Systems improve data quality while Their robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials.

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

InSound Medical, Inc., a privately held, venture-backed company based in Newark, California, develops and manufactures next-generation hearing solutions. Major investors include Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC.

ZettaCom, Inc. manufactures and supplies chipset solutions to core multi-service switch and router original equipment manufacturers (OEMs).

Eunoe, Inc. is a San Francisco Bay-area medical device company focused on the treatment of neurological disorders through the management of cerebrospinal fluid.

Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018TM adjuvant as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, pertussis and universal influenza.

Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population. Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema. Broncus is located in Mountain View, CA (San Francisco Bay area). Broncus International is located in Nyon, Switzerland.

Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. Their proven LogPad and StudyPad Systems improve data quality while Their robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials.

Oresis Communications designs and develops switching systems for carrying voice and data signals on the same telecommunications network. It offers ISIS-700 OmniService Switch, which enables carriers and service providers to migrate circuit and packet switched networks to a single backbone; and ISIS-700 Integrated OmniService Switch, which is a multiservice switch equipment that switches multiple voice, data, Internet, and video services in a single system. The company is based in Beaverton, Oregon.

Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.

Lara Technology is a fabless semiconductor manufacturer that designs, develops and markets memory-intensive ASICs for the networking and communications industries.

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. Their proven LogPad and StudyPad Systems improve data quality while Their robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials.

RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

DynamicSoft provides carrier-class infrastructure software for packet-based wireline and wireless communications networks. The company's infrastructure solutions enable carriers and communications application service providers to deploy telephony applications and converged services over Internet protocol-based networks. Its dynamicsoft Service Engine allows mobile carriers to deliver voice and data services over packet network, as well as provides a migration path to various IP 3G network environments; supports various services, such as voice, multimedia messaging, instant messaging, and presence; and consolidates common functions, which include customer data storage, authentication, authorization, provisioning, and service interaction. The company was founded in 1998 and is based in East Hanover, New Jersey.

As per the transaction announced on April 21, 2008, Instill Corporation was acquired by iTradeNetwork, Inc. Instill Corporation provides spend intelligence solutions for the foodservice industry. It offers supply chain information services, which automates the collection of transactional and process-oriented data from its customers trading partners. The company also provides a suite of hosted applications that helps its customers in managing various business processes, including trade spend management, food spend management, quality and regulatory compliance, promotion management, procurement, food safety, and vendor and product management. It offers its solutions to foodservice manufacturers, operators, and distributors. Instill Corporation was founded in 1993 and is headquartered in San Mateo, California.

Lifespire was created in late 1999 through the merging of 2 companies: Vida Healthcare and inspiria.com. Vida Healthcare, formed in 1996, has worked with hundreds of oncology doctors, nurses and allied health professionals to improve cancer care. Lifespire Their vision is to improve care through shared knowledge. But what does that mean to you, the patient, and your circle of family and friends They serve? It means that They are giving you and the ones closest to you -- your circle of care -- a resource for gathering credible knowledge, support and understanding of your experience with cancer. Some of you may have known us when They were Vida Healthcare. In Their four years as Vida, They delivered clinical support and education services to over 4,000 people experiencing cancer. Now They're bringing that experience and understanding to you. They're doing this in partnership with companies committed to improving the treatment of cancer. And They're using Lifespire.com as Their forum for delivery.

RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

Applicast™, Inc. is the premier, total-solution application service provider (ASP) for aggressive-growth companies. The Applicast Business Applications Network™ offers full-service application outsourcing for mission-critical applications, such as SAP and Siebel, over secure private or Internet connections. Applicast’s unique combination of a world-class application portfolio, targeted FastFit™ Solutions and full-lifecycle services enables its clients to slash the time, costs and risks of deploying top-tier systems. Applicast, which was formerly called Plenan Systems, is a privately held, venture-backed organization.

Centromine offers a browser-based, internet-accessed, enterprise-wide software applications and services for the health care market. Its applications allow behavioral health care programs and providers to manage the delivery and associated quality and cost of services completely over the internet.

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. Their proven LogPad and StudyPad Systems improve data quality while Their robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials.

HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.

Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.